Pentixapharm Holding AG engages in the development of radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company was founded in 2024 and is headquartered in Berlin, Germany.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pentixapharm Holding AG 52 week high is $2.31 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pentixapharm Holding AG 52 week low is $2.31 as of November 22, 2026.
Pentixapharm Holding AG stock price today is $2.31.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Pentixapharm Holding AG 50-day moving average is $2.31.